Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
STR Holdings Inc. ( STRI - Snapshot Report ) posted second-quarter 2012 results with adjusted loss per share of 4 cents, in line with the Zacks Consensus Estimate and narrower than the year-ago loss of 28 cents per share. On a reported basis, loss per share came in at 6 cents compared with earnings of 23 cents per share in the year-ago quarter.
Operational Performance
STR Holdings’ quarterly revenues were $25.1 million, representing a decline of 19.2% sequentially and 65.0% year over year. The sequential decline was primarily due to a 16.6% volume decline and a 2.0% decline in average selling price (“ASP”). On a year-over-year basis, volume declined 53.0% and ASP declined 20.7%. Quarterly revenue came in below the Zacks Consensus Estimate of $27 million.
Gross profit for the second quarter of 2012 was $1.6 million, or 6.3% of sales, compared with $2.0 million, or 6.4% of sales, in the first quarter of 2012. The company was able to maintain its gross margin despite lower sales as a result of its successful cost-reduction efforts, which curtailed cost per square meter sold by 3% sequentially.
Selling, general and administrative expenses for the second quarter of 2012 were $6.7 million compared with $7.7 million in the first quarter of 2012. The reduction was driven by lower labor and incentive compensation expense and lower professional fees. Together, these more than offset increased R&D and selling expenses.
Overall, STR Holdings digested a net loss of $2.4 million versus a net income of $9.7 million in the year-ago quarter.
Financial Performance
STR Holdings reported $72.2 million of cash and cash equivalents at the end of the reported period versus $87.1 million at the end of the year-ago period. Deferred tax liabilities decreased to $46.2 million from $48.6 million at year-end 2011.
Guidance
STR Holdings expects sales for the quarter ending September 30, 2012 to be in the range of $23 million to $25 million. During the quarter it expects its EPS to range between breakeven and a loss of 3 cents.
STR Holdings for full year 2012 expects sales to be in the range of $102 million to $108 million, along with EPS ranging between a penny and 7 cents.
Outlook
Based in Enfield, Connecticut, STR Holdings, Inc. is a diversified global leader providing high quality, superior performance solar encapsulants to the photovoltaic module industry. It is also one of the world's top providers of quality assurance testing, audit, inspection and responsible sourcing services. The company's polymeric PhotoCap products consist primarily of ethylene-vinyl-acetate, or EVA, which is modified with additives and put through its proprietary manufacturing process to increase product stability and make the encapsulant suitable for use in extreme, long-term outdoor applications.
STR Holdings supplies solar module encapsulants to many of the major solar module manufacturers, including First Solar Inc. ( FSLR - Analyst Report ) , and SunPower Corporation ( SPWR - Analyst Report ) . Therefore as direct fallout, STR Holdings along with the whole solar industry is witnessing an oversupply of photovoltaic products leading to a steep drop in Average Selling Prices.
Also, a volatile euro, apprehension over a reduction in European solar subsidies and falling crystalline silicon prices remain a matter of concern for the company.
STR Holdings presently retains a short-term Zacks #4 Rank (Sell). We have a long-term Neutral recommendation on the stock.
Read the full reports :
Analyst Report on FSLR
Snapshot Report on STRI
Analyst Report on SPWR